General
Melting points (uncorrected) were determined on a Reichert-Jung apparatus. Optical rotations were measured in 2 cm cells on a Perkin-Elmer 142 automatic spectropolarimeter. FT-IR spectra were recorded on a Nicolet 550-A spectrometer (KBr pellets). EI-MS spectra were measured by Agilent Technology (HPTM) instrument with 5973 Network Mass Selective Detector (MS model). 1H- and 13C-NMR spectra of CDCl3 solution, running with a Bruker Avance DRX 500 spectrometer operating at 500 and 125 MHz, respectively, are relative to TMS as an internal standard. Chemical shifts (δ) are expressed in ppm and coupling constants (J) in Hz. HPLC analysis was performed using a Waters Alliance system. The column used was Tracer Excel 120 ODS A C18 column (150 × 5 mm, 5 μm). Merck silica gel 60 (70-230 mesh), Merck silica gel 60 (230-400 mesh), Merck TLC silica gel 60 F254 aluminium sheets (20 × 20 cm) and Merck silica gel 60 GF254 were used for column chromatography, medium pressure liquid chromatography (MPLC), analytical and preparative TLC, respectively. With the exception of vincamine standard which was obtained from Sigma-Aldrich, all other chemicals were purchased from Merck Company.
Alkaloid spots on chromatograms were detected under UV-light or by spraying with Dragendroff›s reagent.
Plant material
The aerial parts of V. minor were collected from Zardband Botanical Garden in Gonbad Qabus, Golestan Province, in June 2006. The plant was identified and authenticated by Dr. Gholamreza Amin and the voucher specimen (TEH-6654) was deposited at the Herbarium of the Faculty of Pharmacy in Tehran University of Medical Sciences (Tehran, Iran).
Extraction and isolation
The air-dried and powdered aerial parts of the plant (800 g) were extracted with 80% MeOH at room temperature for 72 h. The procedure was repeated until the negative test against Dragendroff›s reagent. The MeOH extracts were concentrated to give 287 g of crude extract (yield: 35.87%). The crude extract was dissolved in CHCl3 (500 mL) and extracted with 2N HCl (200 mL × 10). The acidic fraction was washed with CHCl3 (200 mL × 3). The pH of the aqueous solution was adjusted to 2. The combined acid fraction was basified with 25% NH3 on the ice chest (pH 10-12) and extracted with CHCl3 (300 mL × 10). CHCl3 was removed under reduced pressure to give 10.9 g of a crude mixture of alkaloids. A mass of 3 g crude alkaloid extract was initially subjected to column chromatography on silica gel (70-230 mesh), eluted with CHCl3-MeOH in a step gradient (99:1, 98:2, 97:3, 96:4, 95:5, 90:10, 80:20, 70:30, 60:40, 50:50, 25:75, and 10:90 v/v; 500 mL each) to give twelve fractions. Fractions with similar TLC behavior were combined to yield the following three major fractions: 1 (0.72 g), 2 (0.85 g) and 3 (0.97 g).
Fraction 1 was purified using a medium pressure liquid chromatography (MPLC) over silica gel (230-400 mesh) with the solvent system of Hexane-EtOAc (8:2) to give 4.2 mg of vincaminorine (1), 4.5 mg of vincaminoreine (2), 12.5 mg of minovine (3), and 6 mg of minovincine (4).
Fraction 2 was subjected to repeated prep. TLC (20 × 20 cm, 0.8 mm thickness) over silica gel eluted with EtOAc-MeOH (9:1) to give 80 mg of vincamine (compound 5) (R:0.40).
Vincaminorine (compound 1)
White crystals, m.p. 130–131°C. [α]D + 48° (EtOH). IR (KBr) νmax cm-1: 3025, 2960, 1717, 1690, 1463, 1374, 1258, 1090, 1018, 769. EI-MS 70 eV, m/z (rel. int.): 354 (43, M+), 339 (1), 323 (2), 295 (3), 268 (3), 229 (100), 210 (6), 184 (3), 170 (5), 149 (6), 124 (17). 1H-NMR (500 MHz, CDCl3) δ: 7.51 (d, J = 7.1, 1H, H-9), 7.26 (1H, covered by solvent peak, H-12), 7.18 (t, J = 7, 1H, H-10), 7.09 (t, J = 7, 1H, H-11), 6.22 (m, 1H, H-16), 3.65 (s, 3H, OMe), 3.61 (s, 3H, NMe), 2.91–2.93 (m, 3H, CH2-14, H-3a), 2.62–2.65 (m, 1H, H-5a), 2.42–2.44 (m, 1H, H-3b), 2.39–2.42 (m, 2H, CH2-17), 2.33–2.39 (m, 1H, H-5b), 2.22 (d, J = 15, 1H, H-21a), 1.83 (d, J = 15, 1H, H-21b), 1.60 –1.62 (m, 1H, H-6a), 1.25–1.29 (m, 2H, CH2-19), 1.07–1.10 (m, 1H, H-6b), 1.03–1.06 (m, 1H, H-15a), 0.97–1.03 (m, 1H, H-15b), 0.66 (t, J = 7, 3H, Me-18). 13C-NMR (125 MHz, CDCl3) δ: 176.36 (CO), 138.75 (C-2), 138.25 (C-13), 128.75 (C-8), 122.40 (C-10), 120.13 (C-11), 119.61 (C-9), 114.00 (C-7), 110.10 (C-12), 62.26 (C-21), 55.52 (C-5), 55.00 (C-3), 53.58 (OMe), 40.36 (C-17), 40.29 (C-16), 37.13 (C-6), 36.47 (C-15), 32.28 (NMe), 28.10 (C-14), 26.32 (C-20), 15.59 (C-19), 8.84 (C-18) (13).
Vincaminoreine (compound 2)
White crystals, m.p. 126°C. [α]D + 26.5° (CHCl3). IR (KBr) νmax cm-1: 3016, 2772, 1760, 1568, 1519, 1491, 1342, 1225, 1073, 760. EI-MS 70 eV, m/z (rel. int.): 354 (83, M+), 339 (3), 325 (3), 295 (8), 268 (9), 229 (100), 210 (60), 184 (13), 170 (19), 149 (9), 124 (43). 1H-NMR (500 MHz, CDCl3) δ: 7.50 (d, J = 7.1, 1H, H-9), 7.24 (1H, covered by solvent peak, H-12), 7.17 (t, J = 7, 1H, H-10), 7.07 (t, J = 7, 1H, H-11), 3.70 (s, 3H, OMe), 3.52 (s, 3H, NMe), 3.16 (d, J = 15, 1H, H-21a), 2.93–2.95 (m, 2H, CH2-17), 2.49–2.51 (m, 1H, H-3a), 2.29–2.33 (m, 1H, H-5a), 2.27–2.29 (m, 1H, H-5b), 2.24–2.27 (m, 1H, H-3b), 1.93–1.96 (m, 1H, H-16), 1.61 (d, J = 15, 1H, H-21b), 1.47 – 1.54 (m, 1H, H-14a), 1.36–1.41 (m, 1H, H-6a), 1.30–1.35 (m.1H, H-15a), 1.25–1.29 (m, 1H, H-14b), 1.20–1.25 (m, 2H, CH2-19), 1.18 – 1.20 (m, 1H, H-15b), 1.16 – 1.18 (m, 1H, H-6b), 0.93 (t, J = 7.2, 3H, Me-18). 13C-NMR (125 MHz, CDCl3) δ: 175.17 (CO), 139.27 (C-2), 136.74 (C-13), 127.05 (C-8), 120.59 (C-10), 118.49 (C-11), 117.96 (C-9), 109.96 (C-7), 108.59 (C-12), 57.88 (C-21), 55.27 (C-5), 53.29 (C-3), 52.48 (OMe), 34.21 (C-6), 33.79 (C-16), 31.01 (C-15), 30.23 (NMe), 24.88 (C-20), 22.45 (C-17), 22.32 (C-14), 14.19 (C-19), 7.39 (C-18) (13).
Minovine (compound 3)
White amorphous substance, m.p. 79–81°C. IR (KBr) νmax cm-1: 3016, 2933, 2854, 2776, 1737, 1676, 1585, 1486, 1433, 1374, 1301, 1215, 759. EI-MS 70 eV, m/z (rel. int.): 352 (40), 337 (1), 321 (3), 293 (2), 267 (4), 252 (4), 228 (5), 207 (3), 182 (4), 168 (9), 124 (100). 1H-NMR (500 MHz, CDCl3) δ: 7.20–7.23 (m, 1H, H-11), 7.18 – 7.20 (m, 1H, H-9), 6.91 (t, J = 5, 1H, H-10), 6.82 (d, J = 7, 1H, H-12), 3.75 (s, 3H, OMe), 3.24 (s, 3H, NMe), 3.11–3.13 (m, 1H, H-3a), 2.92 (d, J = 12.5, 1H, H-17a), 2.87–2.91 (m, 1H, H-5a), 2.60 (s, 1H, H-21), 2.48 (d, J = 12.5, 1H, H-17b), 2.45–2.47 (m, 1H, H-5b), 2.41–2.45 (m, 1H, H-3b), 1.97–2.00 (m, 1H, H-6a), 1.82–1.86 (m, 1H, H-15a), 1.79–1.82 (m, 1H, H-14a), 1.63–1.65 (m, 1H, H-6b), 1.51–1.53 (m, 1H, H-14b), 1.20–1.22 (m, 1H, H-15b), 0.87–0.89 (m, 1H, H-19a), 0.65–0.69 (m, 3H, Me-18), 0.62–0.65 (m, 1H, H-19b). 13C-NMR (125 MHz, CDCl3) δ: 168.00 (CO), 167 (C-2), 146.88 (C-13), 138.59 (C-8), 127.55 (C-11), 121.00 (C-9), 120.82 (C-10), 108.48 (C-12), 92.80 (C-16), 75.37 (C-21), 56.76 (C-7), 52.04 (C-5), 50.94 (OMe), 50.40 (C-3), 46.98 (C-6), 37.26 (C-20), 36.17 (NMe), 32.47 (C-15), 30.25 (C-17), 29.33 (C-19), 22.67 (C-14), 7.00 (C-18) (14).
Minovincine (compound 4)
White amorphous substance, m.p. 141–142°C. IR (KBr) νmax cm-1: 3398, 3025, 2932, 2854, 1739, 1708, 1603, 1468, 1440, 1250, 749. EI-MS 70 eV, m/z (rel. int.): 353(12), 352 (45, M+), 337 (3), 321 (4), 309 (33), 293 (5), 265 (8), 249 (6), 214 (32), 206 (9), 139 (34), 138 (100). 1H-NMR (500 MHz, CDCl3) δ: 8.80 (br s, 1H, NH), 7.34 (d, J = 7.3, 1H, H-9), 7.16 (dt, J = 7.6, 1.2, 1H, H-11), 6.96 (t, J = 7.7, 1H, H-10), 6.81 (d, J = 7.7, 1H, H-12), 3.81 (s, 3H, OMe), 3.30 (d, J = 1.2, 1H, H-21), 3.16–3.18 (m, 1H, H-5a), 3.09 (d, J = 15, 1H, H-17a), 2.99–3.01 (m, 1H, H-3a), 2.84 (d, J = 15, 1H, H-17b), 2.74 – 2.79 (m, 1H, H-5b), 2.49 – 2.54 (m, 1H, H-3b), 1.98 – 2.03 (m, 3H, CH2-14 and H-15b), 1.92 (s, 3H, Me-18), 1.79–1.82 (m, 1H, H-6a), 1.65–1.69 (m, 1H, H-15b), 1.46–1.50 (m, 1H, H-6b). 13C-NMR (125 MHz, CDCl3) δ: 212.50 (C-19), 168.75 (CO), 168.65 (C-2), 142.80 (C-13), 138.60 (C-8), 127.64 (C-9), 121.60 (C-11), 121.11 (C-10), 109.86 (C-12), 91.89 (C-16), 68.13 (C-21), 56.65 (C-7), 54.35 (C-5), 51.91 (OMe), 51.52 (C-3), 50.22 (C-6), 45.70 (C-20), 31.53 (C-17), 26.29 (C-15), 25.50 (C-14), 22.79 (C-18) (15, 16).
Vincamine (compound 5)
White crystals, m.p. 230–233°C. IR (KBr) νmax cm-1: 3430, 3053, 2950, 2927, 1748, 1615, 1457, 1209, 742. EI-MS 70 eV, m/z (rel. int.): 354 (100, M+), 339 (16), 325 (14), 307 (31), 295 (45), 284 (13), 267 (51), 252 (87), 237 (27), 224 (40), 209 (17), 180 (22), 167 (27), 149 (13), 133 (13), 115 (11). 1H-NMR (500 MHz, CDCl3) δ: 7.47–7.49 (m, 1H, H-9), 7.09 – 7.13 (m, 3H, H-10. H-11 and H-12), 4.57 (s, 1H, 14-OH), 3.92 (s, 1H, H-3), 3.82 (s, 3H, OMe), 3.32–3.35 (m, 1H, H-5a), 3.28–3.31 (m, 1H, H-5b), 2.95–3.02 (m, 1H, H-6a), 2.58 – 2.63 (m, 1H, H-6b), 2.54–2.57 (m, 1H, H-19a), 2.49–2.51 (m, 1H, H-19b), 2.25–2.27 (m, 1H, H-20a), 2.22 (d, J = 15.1, 1H, H-15a), 2.12 (d, J = 15.1, 1H, H-15b), 1.70–1.75 (m, 1H, H-17a), 1.66–1.69 (m, 1H, H-18a), 1.47–1.50 (m, 1H, H-20b), 1.42–1.46 (m, 1H, H-17b), 1.35 –1.38 (m, 1H, H-18b), 0.91 (t, J = 7.2, 3H, Me-21). 13C-NMR (125 MHz, CDCl3) δ: 174.89 (CO), 134.56 (C-13), 132.89 (C-8), 129.39 (C-2), 122.13 (C-10), 120.71 (C-12), 118.92 (C-9), 110.75 (C-11), 106.34 (C-7), 82.32 (C-14), 59.59 (C-3), 54.73 (OMe), 51.40 (C-5), 45.01 (C-19), 44.83 (C-15), 35.56 (C-16), 29.32 (C-20), 25.51 (C-18), 21.16 (C-17), 17.25 (C-6), 8.01 (C-21) (17, 18).
HPLC analysis
Chromatographic analysis was performed using a Tracer Excel 120 ODS A C18 column (150 × 5 mm, 5 μm). The mobile phase was an isocratic combination of MeOH : water (75 : 25) (0.02 mol/L NH4Cl, pH = 8.2 adjusted with Et3N) and the flow rate was adjusted to 0.5 mL/min. The detector wavelength was 254 nm and the injection volume was 50 μL. The quantification was carried out by an external standard method. Standard vincamine was purchased from Sigma-Aldrich. Calibration curve was obtained using solutions containing vincamine in concentrations of 50, 100 and 200 μg/mL in MeOH, 3 injections per concentration. A linear relationship between peak area and alkaloid concentration was observed with the regression coefficient r better than 0.9997 for vincamine standard.
Sample preparation
A mass of 5 g of dried ground plant material was extracted in a Soxhlet apparatus with MeOH (50 mL) for 4 h. The solvent was evaporated and the residue was dissolved in CHCl3 (30 mL) and extracted with aqueous 2N HCl (4 ×15 mL). The pH of this solution was adjusted to 10 with 25% NH3 and the alkaloids were taken up in CHCl3 (4 ×15 mL). The combined CHCl3 extracts were concentrated, the residue was dissolved in MeOH and the solution was brought to a final volume of 25 mL in a volumetric flask. The solution was filtered and 50 μL of it was injected onto the HPLC column for 3 times.
Limit of detection and limit of quantization
Limits of detection (LODs) and limits of quantization (LOQs) were calculated using the expressions 3.3 σ/
s and 10 σ/
s, respectively, in which σ is intercept standard deviation and
s is the slope of calibration curve (
19).
Selectivity
For chromatographic method, developing a separation involves demonstrating specificity which is the ability of the method to accurately measure the analyte response in the presence of all interferences. Therefore, the solutions obtained from sample preparation were analyzed and the peaks of analyte were evaluated for peak purity and resolution from the nearest eluting peak.
Precision
The precision of each method indicates the degree of dispersion within a series of determinations of the same sample. Three samples in three levels (80, 100. 120%) were analyzed on the same day (intra-day) for three consecutive days (inter-day) and the relative standard deviations (RSD%) were calculated. Three samples for each level were prepared, each of which was injected to HPLC for three times.
Recovery
This parameter shows the proximity between the experimental values and the real ones. It ensures that no loss or uptake occurred during the process. The determination of this parameter was performed for the method by studying the recovery after a standard addition procedure with two additional levels. The concentrations of standards added to the sample were 50 and 100 μg/mL. In each additional level, three determinations were carried out and the recovery percentage was calculated in every case. Each sample was injected to HPLC three times.